GT Biopharma Inc (GTBP) — Cash Flow Quality Index
Latest as of June 2016:
-0.69x
GT Biopharma Inc (GTBP) has a Cash Flow Quality Index of -0.69x as of June 2016. Operating cash flow of $-1.06 Million is below net income of $1.54 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore GTBP debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-0.69x
Operating CF / Net Income
Operating Cash Flow
$-1.06 Million
USD
Net Income
$1.54 Million
USD
Data as of
Jun 2016
Most recent filing
GT Biopharma Inc Cash Flow Quality Index (1987–2016)
Historical Cash Flow Quality Index for GT Biopharma Inc across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see GTBP cash flow metrics.
Annual Cash Flow Quality Index for GT Biopharma Inc (1987–2016)
Year-by-year earnings quality comparison for GT Biopharma Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2016 | -0.09x | $-1.93 Million | $21.03 Million | ▲ +90.5% |
| 2007 | -0.96x | $-270.00K | $280.00K | ▼ -196.4% |
| 1990 | 1.00x | $900.00K | $900.00K | ▲ +0.0% |
| 1989 | 1.00x | $700.00K | $700.00K | ▲ +0.0% |
| 1988 | 1.00x | $100.00K | $100.00K | ▲ +500.0% |
| 1987 | 0.17x | $50.00K | $300.00K | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.